Tanguay S - Search Results

1

Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.

Nayak JG, Patel P, Saarela O, Liu Z, Kapoor A, Finelli A, Tanguay S, Rendon R, Moore R, Black PC, Lacombe L, Breau RH, Kawakami J, Drachenberg DE. Nayak JG, et al. Among authors: tanguay s. Urology. 2016 Aug;94:154-60. doi: 10.1016/j.urology.2016.03.029. Epub 2016 Mar 31. Urology. 2016. PMID: 27041471

2

Therapy of locally recurrent renal cell carcinoma after nephrectomy.

Tanguay S, Pisters LL, Lawrence DD, Dinney CP. Tanguay S, et al. J Urol. 1996 Jan;155(1):26-9. J Urol. 1996. PMID: 7490850

3

The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter.

Kenworthy P, Tanguay S, Dinney CP. Kenworthy P, et al. Among authors: tanguay s. J Urol. 1996 Feb;155(2):501-3. J Urol. 1996. PMID: 8558645

4

Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery.

Tanguay S, Swanson DA, Putnam JB Jr. Tanguay S, et al. J Urol. 1996 Nov;156(5):1586-9. doi: 10.1016/s0022-5347(01)65454-5. J Urol. 1996. PMID: 8863544 Clinical Trial.

5

Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy.

Karakiewicz PI, Bazinet M, Aprikian AG, Tanguay S, Elhilali MM. Karakiewicz PI, et al. Among authors: tanguay s. Urology. 1998 Dec;52(6):1041-6. doi: 10.1016/s0090-4295(98)00350-1. Urology. 1998. PMID: 9836552

6

The evolving role of radical surgery in the management of regionally advanced transitional cell carcinoma of the bladder.

Aprikian AG, Tanguay S. Aprikian AG, et al. Among authors: tanguay s. Can J Urol. 1998 Dec;5(5):643-651. Can J Urol. 1998. PMID: 11319040

7

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection.

Tanguay S, Bégin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG. Tanguay S, et al. Urology. 2002 Feb;59(2):261-5. doi: 10.1016/s0090-4295(01)01497-2. Urology. 2002. PMID: 11834399

8

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer.

Stephenson AJ, Aprikian AG, Souhami L, Behlouli H, Jacobson AI, Bégin LR, Tanguay S. Stephenson AJ, et al. Among authors: tanguay s. Urology. 2002 May;59(5):652-6. doi: 10.1016/s0090-4295(02)01526-1. Urology. 2002. PMID: 11992834

9

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy.

Ismail A H, Pollak M, Behlouli H, Tanguay S, Begin LR, Aprikian AG. Ismail A H, et al. Among authors: tanguay s. J Urol. 2002 Dec;168(6):2426-30. doi: 10.1016/S0022-5347(05)64160-2. J Urol. 2002. PMID: 12441932

10

Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.

Kassouf W, Tanguay S, Aprikian AG. Kassouf W, et al. Among authors: tanguay s. J Urol. 2003 May;169(5):1742-4. doi: 10.1097/01.ju.0000057795.97626.66. J Urol. 2003. PMID: 12686822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters